Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tanaka

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Elife|January 12, 2026
Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balanceAtsushi Matsumoto, Akihito Inoko, Takuya Tanaka, et al.
Isotopes in Environmental and Health Studies|February 5, 2009
Isotopic composition of nitrogenous compounds with emphasis on anthropogenic loading in river ecosystemsJunko Nishikawa, Ayato Kohzu, Narin Boontanon, et al.
Journal of Cardiovascular Pharmacology|May 3, 2012
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing heartsKazuki Noda, Miyuki Kobara, Junichi Hamada, et al.
In Vivo (Athens, Greece)|January 2, 2026
Association Between PD-L1 Expression and Interstitial Lung Disease Risk in EGFR-mutant NSCLC Treated With EGFR-TKIsYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Anticancer Research|May 27, 2026
Pretreatment Tumor Growth Rate and Clinical Outcomes in Advanced Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Cureus|August 19, 2024
Investigation of the Efficacy of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor in Patients With EGFR Exon 21 L858R Point Mutation-Positive Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Anticancer Research|November 29, 2025
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint InhibitorsYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Cancer Diagnosis & Prognosis|September 3, 2025
Treatment Response and Survival in Thyroid Transcription Factor-1 Negative Non-squamous Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Association Between Pretreatment White Blood Cell Count and Early Progression in Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Respiratory Medicine Case Reports|June 12, 2025
Erythrocytosis as an indicator of disease progression of small cell lung cancer: A case reportTakuya Tanaka, Yutaka Takahara, Ryudai Abe, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Elife|January 12, 2026
Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balanceAtsushi Matsumoto, Akihito Inoko, Takuya Tanaka, et al.
Isotopes in Environmental and Health Studies|February 5, 2009
Isotopic composition of nitrogenous compounds with emphasis on anthropogenic loading in river ecosystemsJunko Nishikawa, Ayato Kohzu, Narin Boontanon, et al.
Journal of Cardiovascular Pharmacology|May 3, 2012
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing heartsKazuki Noda, Miyuki Kobara, Junichi Hamada, et al.
In Vivo (Athens, Greece)|January 2, 2026
Association Between PD-L1 Expression and Interstitial Lung Disease Risk in EGFR-mutant NSCLC Treated With EGFR-TKIsYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Anticancer Research|May 27, 2026
Pretreatment Tumor Growth Rate and Clinical Outcomes in Advanced Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Cureus|August 19, 2024
Investigation of the Efficacy of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor in Patients With EGFR Exon 21 L858R Point Mutation-Positive Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Anticancer Research|November 29, 2025
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint InhibitorsYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Cancer Diagnosis & Prognosis|September 3, 2025
Treatment Response and Survival in Thyroid Transcription Factor-1 Negative Non-squamous Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Association Between Pretreatment White Blood Cell Count and Early Progression in Non-small Cell Lung CancerYutaka Takahara, Ryudai Abe, Sumito Nagae, et al.
Respiratory Medicine Case Reports|June 12, 2025
Erythrocytosis as an indicator of disease progression of small cell lung cancer: A case reportTakuya Tanaka, Yutaka Takahara, Ryudai Abe, et al.
Pageof 6